BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 36146843)

  • 1. Co-Infection and Cancer: Host-Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses.
    Mulherkar TH; Gómez DJ; Sandel G; Jain P
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).
    Casseb J; Posada-Vergara MP; Montanheiro P; Fukumori LM; Olah I; Smid J; Duarte AJ; Penalva de Oliveira AC
    Rev Inst Med Trop Sao Paulo; 2007; 49(4):231-3. PubMed ID: 17823752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of a within-host HIV/HTLV-I co-infection model with immunity.
    Elaiw AM; AlShamrani NH
    Virus Res; 2021 Apr; 295():198204. PubMed ID: 33157165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
    Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
    Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
    Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
    Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
    Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment.
    Futsch N; Mahieux R; Dutartre H
    Viruses; 2017 Dec; 10(1):. PubMed ID: 29267225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediators of central nervous system damage during the progression of human T-cell leukemia type I-associated myelopathy/tropical spastic paraparesis.
    Barmak K; Harhaj EW; Wigdahl B
    J Neurovirol; 2003 Oct; 9(5):522-9. PubMed ID: 13129766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Kubota R; Jacobson S
    J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression.
    Souza FDS; Freitas NL; Gomes YCP; Torres RC; Echevarria-Lima J; da Silva-Filho IL; Leite ACCB; de Lima MASD; da Silva MTT; Araújo AQC; Espíndola OM
    Front Immunol; 2021; 12():737941. PubMed ID: 34764955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV Infections.
    Assone T; Paiva A; Fonseca LA; Casseb J
    Viruses; 2016 Feb; 8(2):. PubMed ID: 26848682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
    Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
    J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Integrin Signaling Activation on the Development of Human T Cell Leukemia Virus-1 (HTLV-1)-Associated Myelopathy/Tropical Spastic Paraparesis: Its Relationship to HTLV-1-Infected CD4
    Nakamura T; Satoh K; Nakamura H; Fukushima N; Nishiura Y; Furuya T; Ichinose K
    AIDS Res Hum Retroviruses; 2018 Apr; 34(4):331-336. PubMed ID: 29400072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
    Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
    Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An altered maturation and adhesion phenotype of dendritic cells in diseased individuals compared to asymptomatic carriers of human T cell leukemia virus type 1.
    Manuel SL; Sehgal M; Khan ZK; Goedert JJ; Betts MR; Jain P
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1273-85. PubMed ID: 23750452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.
    Enose-Akahata Y; Abrams A; Johnson KR; Maloney EM; Jacobson S
    Blood; 2012 Mar; 119(12):2829-36. PubMed ID: 22318200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus and human T-cell lymphotropic virus type 1 co-infection: impact on liver disease, virological markers, and neurological outcomes.
    Espíndola OM; Vizzoni AG; Lampe E; Andrada-Serpa MJ; Araújo AQC; Leite ACC
    Int J Infect Dis; 2017 Apr; 57():116-122. PubMed ID: 28185943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Kodama D; Tanaka M; Matsuzaki T; Izumo K; Nakano N; Matsuura E; Saito M; Nagai M; Horiuchi M; Utsunomiya A; Takashima H; Kubota R; Izumo S
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008361. PubMed ID: 32667912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.